01 3Prevacid/Lansoprazole
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2016 Revenue in Millions : 481
2015 Revenue in Millions : 857
Growth (%) : -44
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2017 Revenue in Millions : 371
2016 Revenue in Millions : 513
Growth (%) : -28
Main Therapeutic Indication : Gastrointestinal Disorders
Currency : USD
2018 Revenue in Millions : 253
2017 Revenue in Millions : 347
Growth (%) : -27%
LOOKING FOR A SUPPLIER?